BACKGROUND: Epidemiological studies have reported conflicting results relating obesity to BPH. A meta-analysis of cohort and case-control studies was conducted to pool the risk estimates of the association between obesity and BPH.
Introduction
BPH and concomitant lower urinary tract symptoms (LUTS) are the most common non-malignant medical conditions of the prostate occurring in middle aged and older men.
1 BPH is an enlargement of the prostate gland tissue and narrowing of the urethra characterized by overgrowth of the transitional and periurethral area resulting from proliferation of stromal and glandular elements. LUTS, generally regarded as primary clinical manifestation of BPH, encompasses disorders of bladder storage or emptying. According to the recent epidemiological study, 2 BPH affects 70% of men 60-69 years old and 80% of those X70 years old. Identification of potentially modifiable factors contributing to its cause may help reduce the burden of this disease.
Body size and composition have long been hypothesized to influence the risk of prostate hyperplasia. Scientific interest in anthropometric measurements and prostate hyperplasia has mainly been focused on height, weight and measures of weight adjusted for height, such as body mass index (BMI) with less interest in waist circumference and its ratio to hips circumference. Although a cluster of published epidemiological evidence demonstrates that obesity may increase the risks of BPH and LUTS, [3] [4] [5] it still lacks the quantitative evidence to certify this association. To provide a comprehensive summary of the relation between obesity and BPH risk, we use the BMI as the measure of obesity to summarize the evidence from the epidemiological literature on this issue. We also sought to address the sources of heterogeneity including study design and geographic distribution.
Materials and methods

Search strategy
A literature search of MEDLINE database using PubMed, Web of Science and the Cochrane Library was conducted to identify potential epidemiological studies up to December 2010. The following key words were used to search the published literature: BPH, LUTS and obesity. References in the retrieved publications, as well as those in previous systematic review, were checked for any other pertinent studies. For inclusion in this analysis, eligible studies had to fulfill all the following inclusion criteria: (a) case-control or cohort study published as an original article; (b) papers reported in English between 1980 and December 2010; and (c) papers providing odds ratio (OR) or relative risk (RR) with corresponding 95% confidence intervals (CI) (95%) adjusted at least for age or sufficient information allowing us to compute them. In studies with overlapping patients or controls, only the latest or the most complete was included. Any study with inconsistent or erroneous data was excluded. Meeting abstracts with insufficient data or unpublished reports were not considered.
Data extraction
Two investigators (SW and QM) independently extracted data from all potentially relevant studies. Conflicting evaluations were resolved by either discussion or thirdparty resolution. Data extracted from these articles included the name of the first author, year of publication, study design, outcomes definition, sample size, geographical region, exposure assessment and the covariates included in the final adjusted models. For studies that reported separate adjusted ORs for several BMI strata, we abstracted the adjusted OR comparing the highest category of BMI with the lowest category (reference group).
Statistical analysis
We performed all statistical analyses utilizing Stata/SE 11.0 (Stata Corporation, College Station, TX, USA) commercial software with the most recent updates for meta-analysis commands. The OR was used as a measure of the RR for all studies, and the RR estimates were log-transformed. The data from individual studies was pooled utilizing the random-effect model with the DerSimonian-Laird method 6 in our analysis, which consider both within-study and between-study variation. We performed subgroup analyses based on likely sources of between-study heterogeneity, such as study design, geographical region and primary outcome of BPH.
For the dose-response meta-analysis, we included studies considering at least three levels of BMI, and providing the number of case patients and control subjects in each exposure category. For results reported in categories of BMI, these were transformed to an estimate per unit increase in BMI. To treat BMI as a continuous exposure variable, we assigned the level of BMI from each study to these categories based on the calculated midpoint of BMI. For open-ended categories the approximate midpoint was set at double the distance between the midpoint and upper bound of the closest category. The log RR, as well as the BMI, for the reference category was set to zero (corresponding to a RR of one). We subtracted the midpoint BMI of this category from the midpoint BMI of all other categories. A weighted regression was then fit through the origin where the exposure was at the reference level with log RR zero. The regression was weighted by the inverse variance of the log RR for each category. The correlation between categories was estimated using method of Greenland et al. Between-study heterogeneity across the eligible comparisons was quantitatively assessed using the w 2 -based Q statistical test and I 2 score. 8, 9 Heterogeneity was considered statistically significant when a two-sided Po0.05. Meta-regression analysis was used to explore the influence of publication year, sample size, geographical region and method of BMI assessment in the heterogeneity. Publication bias assessment was performed using the Egger regression asymmetry test 10 and the Begg adjusted rank correlation test.
11 Po0.05 was considered indicative of significant publication bias.
Result
We identified 188 potentially relevant abstracts in our initial search. Of these, 154 were unrelated or not original research articles. Upon closer examination, 15 studies were excluded for the following reasons: 4 studies [12] [13] [14] [15] were not case-control or cohort studies, 9 studies did not provide sufficient information to estimate a summary OR and its 95% CI [16] [17] [18] [19] [20] [21] [22] [23] or a summary OR adjusted for age. 24 One study 25 evaluated OR and its 95% CI with weight and height, respectively, but no BMI. One study 26 researched the relationship between BPH and BMI in the form of annual growth rates.
The 30, 41 as LUTS. Thus, we pooled the ORs of these four studies mentioned above separately when subgroup analyses were performed according to BPH or LUTS alone.
BPH and LUTS combined
Fifteen studies were included in the meta-analysis. 27, 29, 31, [33] [34] [35] [36] [37] [38] [39] [40] [42] [43] [44] [45] When BPH and LUTS were combined, we observed that the BMI was associated with BPH or LUTS (Figure 1 , OR ¼ 1.23, 95% CI 1.03-1.48) and the summary OR were similar in population-based casecontrol study, whereas the summary OR in cohort study and hospital-based case-control study showed no association between BMI and BPH/LUTS. Heterogeneity was detected (Po0.05) among all studies and in the subgroup of population-based case-control studies. On the contrary, there was no evidence of heterogeneity in cohort and hospital-based case-control studies. To explore the source of the heterogeneity, we pooled the OR estimates by geographical region (United States, Europe, East Asia, Middle East and Austrian). As shown in Table 2 , the OR estimates from subgroups of the United States, Europe, East Asia and Austrian showed that BMI was not associated with the likelihood of BPH/LUTS when analyzed by geographical regions. A positive relationship between BMI and risk of BPH/LUTS was observed in the Middle East, although it only included one study.
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The results from subgroups analyses above were nonheterogeneous except the group of United States. We also used meta-regression analysis to explore the influence of publication year, sample size and method of BMI assessment on the heterogeneity. However, none was identified as a possible source of heterogeneity among all the included studies. No publication bias was found among all studies (P ¼ 0.21 by Egger's test) or in any subgroup either with the Egger's or Begg's test (Table 2) .
We also performed sensitivity analysis by sequentially excluding one study in each turn to examine the influence of a single study on the overall estimate or in any strata. The results showed that none of the study could considerably affect the summary of risk estimates in our meta-analysis (data not shown). It confirmed the stability of our results.
BPH alone
To further explore the association of BMI with BPH alone, we excluded the four studies from analysis that used LUTS as the primary outcome and added four studies 28, 30, 32, 41 mentioned before, and then repeated the pooled analyses. The summary OR of BPH was 1.21 ( Figure 2 , 95% CI 1.00-1.46) for subjects in the highest category of BMI compared with those in the lowest category. The result was heterogeneous and there was no evidence of significant publication bias either with the Egger's or Begg's test in this subgroup.
LUTS alone
Of the studies that used LUTS as the primary outcome one demonstrated an increased likelihood of LUTS 43 and BMI and risk of BPH S Wang et al one a decreased 30 likelihood of LUTS with increased BMI. In this pooled subgroup analysis, the BMI was not significantly associated with the likelihood of LUTS (Figure 2 , OR 1.11, 95% CI 0.84-1.47). There was some evidence of heterogeneity among all these studies. No publication bias was detected among this subgroup.
Dose-response analysis
As in the population-based case-control group, the BMI/ LUTS was associated with increased risk of BPH; we further performed the dose-response analysis for this group. The dose-response meta-analysis included seven studies. [33] [34] [35] 37, [42] [43] [44] An increase in BMI of 1 kg m À2 was statistically significantly associated with a 4.7% ((95% CI 1.5, 8.0%), P heterogenity o0.001). In meta-regression analysis, we explored the influence of publication year, geographical region, sample size, method of BMI assessment and primary outcome in the heterogeneity. However, none of these above was identified as a possible source of heterogeneity among all the included studies.
Discussion
In this pooled analysis of published cohort and casecontrol studies, elevated BMI could increase the risk of BPH or LUTS. Similar risk was seen among populationbased case-control studies group. We also noted a marginal positive association between risk of BPH and increased BMI. Thus, our results may reflect the trend toward increased risk of BPH with increased BMI. Interestingly, the significant association did not extend to LUTS. This observation likely reflects inherent differences between BPH and LUTS as distinct conditions. LUTS is a relatively recent term describing a particular phenotype, that is, a quantifiable manifestation of a group of disorders affecting the prostate and bladder that share a common clinical outcome. The term includes the BPH component but acknowledges that other factors, primarily those related to the bladder, may contribute to the genesis of these symptoms. Thus, the symptom severity does not correlate with prostate volume. Obesity exerts several systemic effects, including increased intra-abdominal pressure which in turn increased bladder pressure and intravesical pressure, with the potential to exacerbate bladder directed LUTS.
The world has globally seen a dramatic rise in the levels of obesity and obesity-related disorders, including hypertension, diabetes mellitus and dyslipidemia. 46 Together these entities comprise the metabolic syndrome, which as defined by the Adult Treatment Panel III includes three or more of the following findings, central obesity (waist circumference 4102 cm), triglycerides more than 150 mg dl
À1
, high-density lipoprotein less than 40 mg dl À1 , BP more than 135/85 mm Hg and fasting plasma glucose more than 110 mg dl
. 47 There has been a conceptual model posits that to a large extent systemic metabolic disturbances may drive BPH pathogenesis. 3 A growing body of evidence has demonstrated increased adiposity, disruptions in glucose homeostasis, lower high-density BMI and risk of BPH S Wang et al lipoprotein cholesterol and higher low-density lipoprotein cholesterol have a strong and independent link with an increased likelihood of BPH. 3, 4 In addition, basic science researches demonstrate physiological connections of metabolic disturbances with BPH. In an animal model, rats fed a high-fat diet, leading to hyperlipidemia, are found to develop prostatic enlargement and bladder overactivity. 48 Obesity has been hypothesized to be associated with BPH because of the endocrine changes in men that occur with age. Abdominal obesity increases the estrogen to androgen ratio and may increase sympathetic nervous activity, both known to influence the development of BPH and the severity of urinary obstructive symptoms. 30 An alternative mechanism for BPH may be related to association of obesity with inflammation and oxidative stress. 49 Analyses of surgical specimens have shown that is usually associated with inflammation 50 and that the extent and severity of the inflammation corresponds to the amount of prostate enlargement. 51 Thus, it is possible that obesity promotes microvascular disease and inflammation, which in turn contribute to ischemia, oxidative stress and an intraprostatic environment favorable to BPH.
In our analysis, further quantitative assay stratified by regional information yielded null results in most subgroups. However, it should still be interpreted with caution considering the limited number of primary studies. The null results could possibly be due to an inadequate number of primary studies to detect the strength of the postulated associations. Also, there existed a possibility that the complex etiology of BPH, which included genetic susceptibility, culture and lifestyles, would probably mask the positive association, whereas a single study in our analysis could not provide sufficient information. But a positive relationship between BMI and risk of BPH/LUTS was observed in Middle East. This difference may, in part, be due to differences in diet, environment and ethic background in this region.
The results of the studies included in this analysis were heterogeneous, likely reflecting differences among study populations, model selection, analytic methodology, exposure assessment and operational definitions of BPH/LUTS. We conducted a meta-regression analysis to assess the effect of publication year, geographical region, study design, primary outcome, sample size and BMI assessment on the heterogeneity. However, none of the confounding factors could explain heterogeneity between the individual studies. Our results from subgroup analysis also could not demonstrate any stratified association. We speculated the variations in extent of adjustment for confounding variables such as dietary or lifestyle characteristics, and uniform outcome assessment may be the source of heterogeneity, but it cannot be verified by meta-regression analysis or subgroup analysis. The presence of heterogeneity indicates the need for consensus definitions for BPH and LUTS in future population-based studies.
As a meta-analysis of previously published observational studies, our study has several limitations that need to be taken into account when considering its contributions. First, because we did not attempt to uncover unpublished observations and not include studies with insufficient information to estimate an adjusted OR, this could have brought a publication bias even though no significant evidence of publication bias was observed in Egger's and Begg's test. Second, the limited number of studies and the heterogeneity in the dose-response metaanalysis could possibly result in inaccurate estimates. Third, the BMI levels in the lowest and highest categories and the range of BMI varied across studies. These differences may have contributed to the heterogeneity among studies in the analysis of the highest versus the lowest categories.
Some articles [52] [53] had hypothesized the reason of inconsistent results for BMI in obesity-related diseases. It was that BMI was an imperfect measure of obesity that combines adipose and non-adipose body components. However, we still used BMI as the measure because there was no feasible variable that could address this issue well in most studies. So it left some problems still in vague. Is the risk of BPH due to increased BMI largely driven by adipose or non-adipose mass or both? Does distribution of adipose mass matter? Future research to confirm these conclusions is warranted.
Conclusions
In summary, this study applied a detailed meta-analytic approach for combining OR estimates from studies on the relationship between BPH and LUTS incidence and BMI. Although we cannot reject the possibility that our estimates were distorted because of residual confounding, the overall current literature suggests significant association on the risk of BPH and obesity; and a further exploration of population-based case-control study in dose-response manner indicated that BMI could increase risk for BPH. However, when the including studies were stratified by study design, geographical region and primary outcome, most of the subgroups shows BMI is not associated with BPH/LUTS.
While this meta-analysis helps resolve some of the inconsistencies with obesity and BPH risk, some do remain. Future researches are needed to confirm these findings and resolve the remaining problems. A greater understanding of what influences risk and progression of BPH would lead to a greater understanding of the likely biological mechanisms for this disease.
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